ArriVent BioPharma, Inc. - Common Stock (NQ:AVBP)

20.86 -1.04 (-4.75%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist

Price and Volume

Volume	399,224
Open	21.88
Bid (Size)	20.83 (1,100)
Ask (Size)	20.86 (500)
Prev. Close	21.90
Today's Range	20.75 - 22.40
52wk Range	15.47 - 29.71
Shares Outstanding	33,697,161
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ArriVent Posts Wider Loss in Fiscal Q2 ↗

August 11, 2025

Via The Motley Fool

Centene, BrightView Holdings, ArriVent BioPharma And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

July 02, 2025

Via Benzinga

Performance

YTD	+0.3%	+0.3%
1 Month	-9.7%	-9.7%
3 Month	+6.3%	+6.3%
6 Month	-8.2%	-8.2%
1 Year	-16.3%	-16.3%

More News

ArriVent Lead Drug Candidate Shows Promise In Lung Cancer Type, Analyst Sees Over 50% Upside ↗

March 20, 2025

Via Benzinga

This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

March 20, 2025

Via Benzinga

Why Logility Supply Chain Solutions Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket ↗

January 27, 2025

Via Benzinga

Discover the 3 Best-Performing Biotech IPO Stocks of 2024

November 06, 2024

Via MarketBeat

AVBP Stock Earnings: ArriVent BioPharma Misses EPS for Q2 2024 ↗

August 14, 2024

Via InvestorPlace

Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million ↗

June 08, 2024

Via Talk Markets

AVBP Stock Earnings: ArriVent BioPharma Beats EPS for Q1 2024 ↗

May 08, 2024

Via InvestorPlace

ArriVent BioPharma Reports First Quarter 2024 Financial Results

May 08, 2024

From ArriVent BioPharma, Inc.

Via GlobeNewswire

ArriVent Appoints Kristine Peterson to its Board of Directors

April 22, 2024

From ArriVent BioPharma, Inc.

Via GlobeNewswire

ProfoundBio Discovers The Joys Of Having A Wealthy Owner ↗

April 08, 2024

Via Benzinga

Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal ↗

March 30, 2024

Via Talk Markets

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying ↗

February 02, 2024

Via Benzinga

KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower ↗

January 28, 2024

Via Talk Markets

Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China ↗

January 27, 2024

Via Talk Markets

Frequently Asked Questions

Is ArriVent BioPharma, Inc. - Common Stock publicly traded?

Yes, ArriVent BioPharma, Inc. - Common Stock is publicly traded.

What exchange does ArriVent BioPharma, Inc. - Common Stock trade on?

ArriVent BioPharma, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for ArriVent BioPharma, Inc. - Common Stock?

The ticker symbol for ArriVent BioPharma, Inc. - Common Stock is AVBP on the Nasdaq Stock Market

What is the current price of ArriVent BioPharma, Inc. - Common Stock?

The current price of ArriVent BioPharma, Inc. - Common Stock is 20.86

When was ArriVent BioPharma, Inc. - Common Stock last traded?

The last trade of ArriVent BioPharma, Inc. - Common Stock was at 01/16/26 04:00 PM ET

What is the market capitalization of ArriVent BioPharma, Inc. - Common Stock?

The market capitalization of ArriVent BioPharma, Inc. - Common Stock is 702.92M

How many shares of ArriVent BioPharma, Inc. - Common Stock are outstanding?

ArriVent BioPharma, Inc. - Common Stock has 703M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.